News and History
-
Texas Reports more than 400 measles cases, a nearly 30 percent increase from previous week
Read More: Texas Reports more than 400 measles cases, a nearly 30 percent increase from previous weekOn Mar. 28, 2025, the Texas Department of State Health Services (DSHS) reported updated information about an outbreak…
-
Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual Health
Read More: Visby Medical Receives Landmark FDA De Novo Authorization for First-Ever OTC PCR Test for Sexual HealthOn Mar. 28, 2025, Visby Medical™ announced that the U.S. Food and Drug Administration (FDA) has granted De…
-
FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
Read More: FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or BOn Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
-
Utah becomes the first state to ban fluoride in public drinking water
Read More: Utah becomes the first state to ban fluoride in public drinking waterOn Mar. 27, 2025, Utah become the first state to ban fluoride in public drinking water, over opposition…
-
SickKids launches trailblazing artificial intelligence program for paediatric health
Read More: SickKids launches trailblazing artificial intelligence program for paediatric healthOn Mar. 27, 2025, The Hospital for Sick Children (SickKids) announced it is harnessing the transformative potential of…
-
CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
Read More: CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and DevelopmentOn Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
-
U.S. biotechs warn tariffs could impede access to cures, stifle innovation
Read More: U.S. biotechs warn tariffs could impede access to cures, stifle innovationOn Mar. 26, 2025, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the…
-
Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
Read More: Merck buys rights to heart disease drug in latest China deal worth up to $2 billionOn Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
-
New Evidence Links Microplastics with Chronic Disease
Read More: New Evidence Links Microplastics with Chronic DiseaseOn Mar. 25, 2025, research from the American College of Cardiology reported that tiny fragments of plastic have…
-
GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infections
Read More: GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infectionsOn Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
